(Q37799085)

23 August 2017

1 reference

title

Methotrexate--the rapidly acting drug (English)

1 reference

23 August 2017

1 reference

Songsiridej N

1

1 reference

PubMed ID

2093441

23 August 2017

Furst DE

series ordinal

2

1 reference

PubMed ID

2093441

23 August 2017

language of work or name

1 reference

1 December 1990

1 reference

Bailliere's clinical rheumatology

23 August 2017

1 reference

23 August 2017

4

1 reference

23 August 2017

3

1 reference

23 August 2017

575-593

1 reference

Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment

23 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Cryptococcosis associated with low-dose methotrexate for arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Complications in methotrexate treatment of psoriasis with particular reference to liver fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Pharmacokinetics of subcutaneous methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Polygammaglutamyl metabolites of methotrexate.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Hepatic ultrastructure after methotrexate therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Methotrexate: clinical pharmacology, current status and therapeutic guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Acute lung disease associated with low-dose pulse methotrexate therapy in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Methotrexate Hepatotoxicity in Psoriasis--Comparison of Different Dose Regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Low-dose methotrexate kinetics in arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Methotrexate pneumonitis after low-dose therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Retention and distribution of liposome-entrapped [3H]methotrexate injected into normal or arthritic rabbit joints

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Rational use of disease-modifying antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Intra-articular methotrexate. Clinical and laboratory study in rheumatoid and psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A twenty-four-week controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Cytokine modulation of chondrocyte proteinase release

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Methotrexate therapy in rheumatoid arthritis: 15 years experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Pharmacokinetics of methotrexate in continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Progressive interstitial lung disease from prolonged methotrexate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Update after a mean of fifty-three months

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

The effect of organic acids on renal clearance of methotrexate in man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Alteration of methotrexate metabolism in rats by administration of an elemental liquid diet. I. Changes in drug enterohepatic circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Folic acid treatment in methotrexate-treated rheumatoid arthritis patients: comment on the article by Furst and Kremer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

METABOLIC STUDIES OF THE EFFECTS OF METHOTREXATE.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Pulse methotrexate therapy in rheumatoid arthritis. A controlled prospective roentgenographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Antiproliferative effects of methotrexate on peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Immunologic studies of rheumatoid arthritis patients treated with methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Can food influence the absorption of methotrexate in children with acute lymphoblastic leukaemia?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Removal of methotrexate, leucovorin, and their metabolites by combined hemodialysis and hemoperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Methotrexate guidelines--revised

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

No Increase in Second Tumors after Cytotoxic Chemotherapy for Gestational Trophoblastic Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Evidence of nonlinear pharmacokinetics of methotrexate in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

The effects of methotrexate on the production and activity of interleukin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Clinical Pharmacokinetics of Methotrexate1

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Interactions with the protein binding of 7-hydroxy-methotrexate in human serum in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Pharmacokinetics of 7-hydroxy-methotrexate and methotrexate in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Methotrexate used for psoriasis and the risk of noncutaneous or cutaneous malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Response of the rat small-intestine epithelium to methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Methotrexate bioavailability after oral and intramuscular administration in children

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Methotrexate in rheumatoid arthritis. Indications, contraindications, efficacy, and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Methotrexate inhibits the leukotriene B4 induced intraepidermal accumulation of polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Pregnancies after chemotherapy of trophoblastic neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Reproductive performance of women successfully treated for gestational trophoblastic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Clinical pharmacokinetics of methotrexate in children

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

A prospective study of the effects of weekly oral methotrexate on liver biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Efficacy of low-dose methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Low-dose methotrexate treatment of rheumatoid arthritis. Long-term observations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Central nervous system toxicity associated with weekly low-dose methotrexate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Methotrexate pharmacokinetics after intraarticular injection in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Methotrexate therapy in rheumatoid arthritis. Current status

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Methotrexate in the treatment of rheumatoid arthritis; pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980008-1

7 January 2021

10.1016/S0950-3579(05)80008-1

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

2093441